As of 2025-06-02, the Intrinsic Value of Mochida Pharmaceutical Co Ltd (4534.T) is 4,442.68 JPY. This 4534.T valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 2,993.00 JPY, the upside of Mochida Pharmaceutical Co Ltd is 48.40%.
The range of the Intrinsic Value is 3,539.14 - 6,898.91 JPY
Based on its market price of 2,993.00 JPY and our intrinsic valuation, Mochida Pharmaceutical Co Ltd (4534.T) is undervalued by 48.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 3,539.14 - 6,898.91 | 4,442.68 | 48.4% |
| DCF (Growth 10y) | 3,598.28 - 6,566.31 | 4,403.08 | 47.1% |
| DCF (EBITDA 5y) | 3,056.02 - 3,384.10 | 3,200.29 | 6.9% |
| DCF (EBITDA 10y) | 3,319.33 - 3,761.22 | 3,515.28 | 17.5% |
| Fair Value | 2,067.41 - 2,067.41 | 2,067.41 | -30.93% |
| P/E | 1,721.28 - 2,040.29 | 1,844.52 | -38.4% |
| EV/EBITDA | 2,821.96 - 3,164.58 | 2,988.52 | -0.1% |
| EPV | 3,604.39 - 4,382.98 | 3,993.68 | 33.4% |
| DDM - Stable | 1,869.64 - 6,538.48 | 4,204.07 | 40.5% |
| DDM - Multi | 2,454.41 - 6,316.15 | 3,494.31 | 16.7% |
| Market Cap (mil) | 108,915.27 |
| Beta | 0.67 |
| Outstanding shares (mil) | 36.39 |
| Enterprise Value (mil) | 63,761.27 |
| Market risk premium | 6.13% |
| Cost of Equity | 6.00% |
| Cost of Debt | 4.25% |
| WACC | 5.99% |